Central Asian Research Index

Tibbiyot, ta’lim va innovatsion tadqiqotlar, 2026, т. 2, № 11, с. 123-128

ВЛИЯНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ НА РАЗВИТИЕ ОСТЕОПОРОЗА: ПАТОГЕНЕТИЧЕСКИЕ МЕХАНИЗМЫ, ФАКТОРЫ РИСКА И КЛИНИЧЕСКОЕ ЗНАЧЕНИЕ

Олтин Лутфуллаев

Аннотация · Abstract

Proton pump inhibitors (PPIs) are widely used to manage acid-related gastrointestinal disorders. Their potential long-term effects on bone mineral density, osteoporosis, and fragility fractures remain clinically relevant. This narrative review synthesizes the evidence regarding associations between PPI use and fractures, as well as proposed underlying mechanisms, including altered calcium salt solubility and absorption under conditions of acid suppression, hypomagnesemia, and possible changes in bone remodeling. Observational studies and meta-analyses report associations between PPI exposure and fractures; however, heterogeneity among the findings and residual confounding limit causal interpretation. Current clinical guidance does not recommend routine bone mineral density testing or prophylactic calcium and vitamin D supplementation solely on the basis of PPI use in patients without additional skeletal risk factors. Periodic reassessment of treatment indications, use of the lowest effective dose, and individualized fracturerisk assessment remain central to appropriate clinical practice.

Сведения · Details